Exogenous Hsp70 attenuates nitroglycerin-induced migraine-like symptoms in mice.

The study suggests that exogenous HSP70 may be a potential therapy for alleviating migraine symptoms and our promising finding warrants further investigation of HSP70 for clinical application.